Abstract

Background: A parotid gland is a large salivary gland positioned just in front of the ears as well as under the cheekbones. Parotid tumors constitute nearly ninety percent for salivary gland tumors; the majority are benign. Parotidectomy is a surgical operation that occurs when a portion or the entire of parotid gland is surgically removed. Objective: This paper was designed as a retrospective study aimed to assessing and analyzing the results of Iraqi patients who underwent parotidectomy in the ENT department. Patients and methods: 70 patients who participated in endoscopic Parotidectomy surgery were recruited, and their ages ranged between 40 and 60 years. Clinical and surgical data were collected during and after Endoscopic parotidectomy surgery from different hospitals in Iraq for a period ranging from January 6, 2022, to September 25, 2023, which included both the surgery time, estimated blood loss rate, blood pressure and heart rate tests, length of stay in the hospital, admission to the care unit, mortality rate, as well as determining the rate of complications, degree of pain, rate of spread of symptoms, and quality of life after surgery. Results: Our findings enrolled clinical outcomes of endoscopic Parotidectomy, which include surgery time was 228.13 ± 4.5 min, rate of bleeding rate was 9 cases, recovery time was 3.8 ± 0.23 weeks, heart rate was 102.56 ± 30.89 BPM, systolic blood pressure was 133.78 ± 43.20 mm Hg, diastolic blood pressure was 79.58 ± 11.72 mm Hg, length of stay in hospital was 3.35 ± 0.11 days, admission to the intensive care unit was included 5 cases, death rate included only one case, postoperative complications included 4 cases, where the most factors were infection got 2 cases, salivary fistula got 1 case, and scars got 1 case. Conclusion: The current study indicates that Endoscopic parotidectomy surgery is the safest and most effective treatment that provides a high recovery rate and a low mortality rate for patients with the parotid gland